Whey Protein Demand Soars 19.3% Amid GLP-1 Surge; Commodity Dairy Slumps
Arla Foods Ingredients reports a 19.3% revenue jump to €867 million in H1 2026, driven by higher whey protein prices and GLP-1 related nutrition demand, sharply contrasting with a 7% decline in commodity dairy sales.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
Copenhagen, Denmark — 27 August 2026
Arla Foods Ingredients achieved a 19.3% year-on-year revenue increase in the first half of 2026, reaching €867 million. This growth, detailed in their H1 2026 results, stems from elevated whey protein prices and robust demand for value-added nutrition ingredients. Arla attributes this performance to persistent strength in whey-based ingredient demand, particularly linked to health and nutrition trends, including the nutritional requirements of consumers utilising GLP-1 weight-loss medications.
Value-added ingredient volumes expanded by 5.7% during the period, with the value-add share of ingredients increasing to 84.6% from 82.9% year-on-year. This growth underscores a significant divergence in dairy markets. Specialised whey proteins are commanding premium pricing due to strong nutrition sector demand, while conventional dairy commodities face downward pressure from abundant European milk supplies. Arla’s consumer-facing protein brands, such as Arla Skyr and Arla Protein, also demonstrated strong growth, up 39.6% and 34.4% respectively, confirming a broader consumer trend towards protein-enriched products.
Conversely, Arla’s Global Industry Sales business reported a 7% revenue decline to €1.18 billion in H1 2026. This was driven by an average 27.3% price drop for butter, skimmed milk powder, and Gouda compared to H1 2025. This dynamic highlights increased milk availability across Europe exerting pressure on global commodity markets. Arla's performance price, a key metric for farmers, fell to 43.6 euro cents per kilogram from 57.5 euro cents year-on-year, reflecting this commodity market weakness.
The company is committing to long-term dairy demand, investing €322 million in H1 2026, and approving a further €300 million investment in a new cheese dairy at its Götene site in Sweden. This expansion, set to double milk intake to 1 billion kilograms annually by 2030, signals confidence in sustained demand for dairy-derived ingredients, albeit with a clear strategic focus on value-added applications.
What this means for United Kingdom
UK supplement manufacturers and brand owners must anticipate continued upward pressure on whey protein isolate and concentrate pricing, impacting gross margins. Reformulation windows for high-protein products should be assessed by Q1 2027 to mitigate cost increases or explore alternative protein sources. Brands targeting weight management or healthy ageing demographics will find a growing market segment in GLP-1 medication users, necessitating product innovation with specific nutritional profiles. Procurement teams should diversify dairy commodity suppliers where possible to manage price volatility, as conventional dairy items remain subject to oversupply. Competitive positioning demands clear differentiation in protein quality and sourcing transparency to capture consumer trust amid these market shifts.
This trend is being actively addressed by UK manufacturing partners including Supplement Factory.